GenFit gets $135M Nasdaq IPO for NASH, PBC hopes

Submitted by admin on March 27, 2019 - 10:21am

Source:

Fierce Biotech

News Tags:

Headline:

snippet:

Already on the Euronext stock exchange, liver disease biotech GenFit has made the jump to the more lucrative Nasdaq with a $135 million IPO.

Search form